<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170715035087N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-04-07</date_registration>
      <primary_sponsor>Zahedan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of laser for the therapy of microbial infection in the root of teeth</public_title>
      <acronym></acronym>
      <scientific_title>The effect comparison of the diode laser 940 nm and triple antibiotic on Minocycline resistance genes (Tet M , Tet W , Tet L ) in Enterococcus faecalis isolated from primary root canal infections</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>150</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/28227</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: patients was randomly assigned to 1 of the 3 designated
groups. Randomization was developed to eliminate any bias on
the part of the investigators and to balance the number of patients
between the treatment protocol types. Using an equal proportion
randomization allocation ratio, 1 of the investigators (A.G.) created
envelopes that contained concealed assignment codes that were assigned
sequentially to eligible patients. It was ensured that neither the
primary investigator nor the patient was aware of the treatment protocol.</study_design>
      <phase>2</phase>
      <hc_freetext>Infection of root canal system.</hc_freetext>
      <i_freetext>Intervention 1: Laser therapy with a 2-watt diode laser(EPIC X ,BIOLASE,Irvine,CA  92618, USA) is used continuously and for each canal three times in one session.laser tip(EZTIP400&amp;300). Intervention 2: laser and medication: First, laser diode (EPIC X ,BIOLASE,Irvine,CA  92618, USA)is shoot,The laser tip enters Only in the first session, three times,in  root canal then the triple antibiotic will be dress in the root canal for a week.Triple antibiotic paste using the ratio: two tablets of metronidazole 250mg (Tehran chemie), two ciprofloxacin 250 mg tablets (Daroupakhsh-Tehran-Iran) and 5 tablets of minocycline 100 mg (Iran darou) to achieve a 1: 1: 1 ratio , Combined). Intervention 3: Control group: triple antibiotic;Triple antibiotic paste using the ratio: two tablets of metronidazole 250mg (Tehran chemie), two ciprofloxacin 250 mg tablets (Daroupakhsh-Tehran-Iran) and 5 tablets of minocycline 100 mg (Iran darou) to achieve a 1: 1: 1 ratio , Combined) The drug enters the canal with Lentulo, it remains within the root canal For a week.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Part of the individual data and information with the outcomes including the counting of bacteria and the prevalence of faecalis in the root canal and the occurrence of antibiotic resistance genes could be shared

When:
6 months after printing results

To whom:
Researchers working in academia and scientific institutions

Conditions:
In order to replicate scientific studies and development, data can be used

Where to obtain:
To the corresponding author

How to obtain:
Administrative correspondence through the deputy of research and technology

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Forough Farahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry,East Azadegan Street, Zahedan,</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816864997</zip>
        <telephone>+98 54 3342 3141</telephone>
        <email>f_farahi67@yahoo.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Eshaghali saberi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry, Azadegan Street, Zahedan</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9817699693</zip>
        <telephone>+98 54 3344 1824</telephone>
        <email>saberiendo@yahoo.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The patients with age ranges from 15 to 60 years who visit the Department of Endodontics at the Faculty of Dentistry in Zahedan, and are diagnosed as "necrotic pulp" with and without periapical involvement after having performed the vitality test
The patients whose teeth are closed apex, with no connection between canal pulp and oral cavity
The patients with no medical records in endodontic treatment, root resorption, calcification, and periodontal pocket with the depth at least 5 mm.
The patients who have not been hospitalized within last three months and have not consumed antibiotics</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The observation of necrotic pulp after entering the pulp chamber and root canal, or due to the traumatic necrosis
The inability to isolate the tooth which results in the contamination of the treatment environment by saliva
Pregnancy
Patients who remember taking antibiotics during treatment
The patient's disinterest in participating in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>B99</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other and unspecified infectious diseases</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Laser therapy with a 2-watt diode laser(EPIC X ,BIOLASE,Irvine,CA  92618, USA) is used continuously and for each canal three times in one session.laser tip(EZTIP400&amp;300)</i_keyword>
      <i_keyword>laser and medication: First, laser diode (EPIC X ,BIOLASE,Irvine,CA  92618, USA)is shoot,The laser tip enters Only in the first session, three times,in  root canal then the triple antibiotic will be dress in the root canal for a week.Triple antibiotic paste using the ratio: two tablets of metronidazole 250mg (Tehran chemie), two ciprofloxacin 250 mg tablets (Daroupakhsh-Tehran-Iran) and 5 tablets of minocycline 100 mg (Iran darou) to achieve a 1: 1: 1 ratio , Combined)</i_keyword>
      <i_keyword>Control group: triple antibiotic;Triple antibiotic paste using the ratio: two tablets of metronidazole 250mg (Tehran chemie), two ciprofloxacin 250 mg tablets (Daroupakhsh-Tehran-Iran) and 5 tablets of minocycline 100 mg (Iran darou) to achieve a 1: 1: 1 ratio , Combined) The drug enters the canal with Lentulo, it remains within the root canal For a week</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Number of bacteria in the root canal. Timepoint: before intervention, after intervention. Method of measurement: real time PCR.</prim_outcome>
      <prim_outcome>Investigation and expression of minocyclin resistant genes in Enterococcus faecalis. Timepoint: before intervention, after intervention. Method of measurement: PCR.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zahedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-10-08</approval_date>
        <contact_name>Ethics committee of Zahedan university of medical sciences</contact_name>
        <contact_address>Dr Hesabi Square, Zahedan Zahedan Sistan-va-Balouchestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
